These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 9149844)
41. Oligonucleotide treatment of ras-induced tumors in nude mice. Wickstrom E Mol Biotechnol; 2001 May; 18(1):35-55. PubMed ID: 11439698 [TBL] [Abstract][Full Text] [Related]
42. Inhibition of hepatitis B virus in vitro by antisense oligonucleotides. Yao ZQ; Zhou YX; Guo J; Feng ZH; Feng XM; Chen CX; Jiao JZ; Wang SQ Acta Virol; 1996 Feb; 40(1):35-9. PubMed ID: 8886096 [TBL] [Abstract][Full Text] [Related]
43. Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer. Watson PH; Pon RT; Shiu RP Cancer Res; 1991 Aug; 51(15):3996-4000. PubMed ID: 1855215 [TBL] [Abstract][Full Text] [Related]
44. Cellular proteins prevent antisense phosphorothioate oligonucleotide (SdT18) to target sense RNA (rA18): development of a new in vitro assay. Brukner I; Tremblay GA Biochemistry; 2000 Sep; 39(37):11463-6. PubMed ID: 10985792 [TBL] [Abstract][Full Text] [Related]
45. Reversal of drug sensitivity in MDR subline of P388 leukemia by gene-targeted antisense oligonucleotide. Nakashima E; Matsushita R; Negishi H; Nomura M; Harada S; Yamamoto H; Miyamoto K; Ichimura F J Pharm Sci; 1995 Oct; 84(10):1205-9. PubMed ID: 8801335 [TBL] [Abstract][Full Text] [Related]
46. Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design. Braasch DA; Liu Y; Corey DR Nucleic Acids Res; 2002 Dec; 30(23):5160-7. PubMed ID: 12466540 [TBL] [Abstract][Full Text] [Related]
47. Myotonic dystrophy: antisense oligonucleotide inhibition of DMPK gene expression in vitro. Galderisi U; Cipollaro M; Melone MA; Iacomino G; Di Bernardo G; Galano G; Contrufo R; Zappia V; Cascino A Biochem Biophys Res Commun; 1996 Apr; 221(3):750-4. PubMed ID: 8630033 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of expression of the multidrug resistance-associated P-glycoprotein of by phosphorothioate and 5' cholesterol-conjugated phosphorothioate antisense oligonucleotides. Alahari SK; Dean NM; Fisher MH; Delong R; Manoharan M; Tivel KL; Juliano RL Mol Pharmacol; 1996 Oct; 50(4):808-19. PubMed ID: 8863825 [TBL] [Abstract][Full Text] [Related]
49. Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Ernfors P; Ibáñez CF; Ebendal T; Olson L; Persson H Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5454-8. PubMed ID: 2164684 [TBL] [Abstract][Full Text] [Related]
50. Rapid screening method for antisense oligonucleotides against human growth factor receptor p185(erbB-2). Rohmann A; Lochmann D; Weyermann J; Bertling WM; Dingermann T; Zimmer A Oligonucleotides; 2004; 14(1):1-9. PubMed ID: 15104891 [TBL] [Abstract][Full Text] [Related]
51. Transfection protocol for antisense oligonucleotides affects uniformity of transfection in cell culture and efficiency of mRNA target reduction. Reed CA; Peralta ER; Wenrich LM; Wong CA; Bennett CF; Freier S; Lollo B Oligonucleotides; 2005; 15(1):12-22. PubMed ID: 15788897 [TBL] [Abstract][Full Text] [Related]
53. Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent. Santiago FS; Atkins DG; Khachigian LM Am J Pathol; 1999 Sep; 155(3):897-905. PubMed ID: 10487847 [TBL] [Abstract][Full Text] [Related]
54. Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism. Missale C; Losa M; Sigala S; Balsari A; Giovanelli M; Spano PF Mol Endocrinol; 1996 Mar; 10(3):272-85. PubMed ID: 8833656 [TBL] [Abstract][Full Text] [Related]
55. Lipofectin enhances cellular uptake of antisense DNA while inhibiting tumor cell growth. Yeoman LC; Danels YJ; Lynch MJ Antisense Res Dev; 1992; 2(1):51-9. PubMed ID: 1422086 [TBL] [Abstract][Full Text] [Related]
56. Single-stranded phosphodiester and phosphorothioate oligonucleotides bind actinomycin D and interfere with tumor necrosis factor-induced lysis in the L929 cytotoxicity assay. Stull RA; Zon G; Szoka FC Antisense Res Dev; 1993; 3(3):295-300. PubMed ID: 8286930 [TBL] [Abstract][Full Text] [Related]
57. Biological and immunological properties of recombinant human, rat, and chicken nerve growth factors: a comparative study. Ibáñez CF; Hallböök F; Söderström S; Ebendal T; Persson H J Neurochem; 1991 Sep; 57(3):1033-41. PubMed ID: 1861142 [TBL] [Abstract][Full Text] [Related]
58. An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts. Veenstra TD; Fahnestock M; Kumar R Biochemistry; 1998 Apr; 37(17):5988-94. PubMed ID: 9558335 [TBL] [Abstract][Full Text] [Related]
59. Uptake of antisense oligonucleotides and functional block of acetylcholine receptor subunit gene expression in primary embryonic neurons. Yu C; Brussaard AB; Yang X; Listerud M; Role LW Dev Genet; 1993; 14(4):296-304. PubMed ID: 7693387 [TBL] [Abstract][Full Text] [Related]
60. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides. Alt M; Renz R; Hofschneider PH; Paumgartner G; Caselmann WH Hepatology; 1995 Sep; 22(3):707-17. PubMed ID: 7657273 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]